Companies
Shiok Meats
a Singapore pioneer of cell-cultivated crustaceans — shrimp, lobster and crab — that is merging with Umami Bioworks to pool cell-line and scale-up assets for the Asia-Pacific market.
- Country
- Singapore
SFA pathway
Pilot
Coverage
| CN | EU | US | |
|---|---|---|---|
| food-alt-protein | ✓ | ✓ | ✓ |
Regulatorsfdaefsamoa-china
Verifiable facts
| Fact | Value | Source |
|---|---|---|
| Funding | Over $30 million in total funding raised since 2018 | agfundernews.com · foodnavigator.com · wipo.int |
| Capacity | Operated at least 50-liter and 200-liter bioreactor scale prior to merger medium confidence | agfundernews.com · time.com · foodnavigator.com · greenqueen.com.hk |
| Certification | EU-granted patent for cultivated crustacean technologies | foodnavigator.com · seafoodsource.com |
| Regulatory approval | None received for commercial sale of products as of the merger; Singapore has a supportive regulatory framework for cultivated meat | time.com · foodnavigator.com |
| Production site | Mini-plant/headquarters in Singapore | time.com · foodnavigator.com |
| Headcount | Grew from less than 5 to over 40 personnel within four years of founding (as of 2022) | foodnavigator.com · wipo.int |
Independent sources: agfundernews.com · foodnavigator.com · greenqueen.com.hk · seafoodsource.com · time.com · wipo.int
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Cultured seafood | food-alt-protein | Medium | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.